Harwood Feffer LLP Announces Investigation of Continucare Corporation

NEW YORK--(BUSINESS WIRE)--Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Continucare Corporation (“Continucare”) (NYSE: CNU) concerning the proposed acquisition by Metropolitan Health Networks, Inc. (NYSE AMEX: MDF) (“Metropolitan”) for all of the outstanding shares of common stock of Continucare for $6.25 per share in cash and 0.0414 of a share of Metropolitan (which, based upon the share price at the time of the announcement, is equal to approximately $0.20). The transaction is currently valued at $416 million. In addition, shareholders who collectively own approximately 43% of Continucare stock have agreed to vote their shares in favor of the proposed merger.